表纸
市场调查报告书

微创脊椎压迫性骨折 (MIVCF) 治疗的全球市场分析

Minimally Invasive Vertebral Compression Fracture Treatments | Medtech 360 | Market Insights | Global

出版商 Decision Resources Group - Medtech 商品编码 192335
出版日期 内容资讯 英文
商品交期: 最快1-2个工作天内
价格
微创脊椎压迫性骨折 (MIVCF) 治疗的全球市场分析 Minimally Invasive Vertebral Compression Fracture Treatments | Medtech 360 | Market Insights | Global
出版日期: 2019年03月25日内容资讯: 英文
简介

全球微创脊椎压迫性骨折 (MIVCF) 治疗市场,由于人口高龄化和肥胖症患者增加等要素,预计今后也将持续扩大趋势。还有新产品的认证和上市,高性能、高价格的治疗技术引进等好消息相继出现,预计抵销各种负面因素 (医疗费偿付额的降低等) 。

本报告提供全球微创脊椎压迫性骨折 (MIVCF) 治疗的市场相关分析,整体市场结构和趋势预测 (今后10年份),各领域详细趋势,市场竞争状况 (主要企业的市场占有率等),主要的推动及阻碍市场要素等相关调查。

摘要

摘要整理

更新履历

微创脊椎压迫性骨折 (MIVCF) 治疗市场

  • 市场概要
    • 美国,欧洲,亚太地区
  • 市场定义
  • 市场预测资料
  • 竞争概要
  • 市场占有率
  • 竞争要素与策略
    • 临床资料
    • 医疗费偿付
    • 价格策略和购买选择
    • 企业合并、收购 (M&A),事业联盟
    • 医生训练/行销
    • 领先者利益
    • 产品改良,技术开发
  • 市场动静

椎体形成市场

  • 市场概要
  • 市场定义
  • 市场预测资料
  • 竞争概要
  • 市场占有率
  • 竞争要素与策略

脊椎增强市场

  • 市场概要
  • 市场定义
  • 市场预测资料
  • 竞争概要
  • 市场占有率
  • 竞争要素与策略

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: M360VE0007

The global MIVCF treatment device market will be driven mainly by the growing aging and obese population across the globe. Furthermore, new product launches and increasing adoption of advanced premium-priced technologies will help overcome obstacles such as unfavorable reimbursement environments. Therefore, the market will see moderate growth through 2027.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for MIVCF treatment devices in the global region across a 10-year period.

Large MNCs continue to dominate the moderately expanding global MIVCF treatment market, bolstering share through mergers and acquisitions and product launches.

Which competitors lead the MIVCF treatment market globally, and what factors contribute to their success in this space?

What strategies can local and international players implement to capture share in the global MIVCF treatment market?

What types of mergers and acquisitions have occurred in recent years, and how do they affect market shares?

There have been few product launches in the vertebroplasty market.

What factors are contributing to a lack of manufacturer focus in the vertebroplasty market?

What can companies competing in the vertebroplasty market do to maintain or gain shares?

Several studies and reports are showing vertebroplasty and vertebral augmentation to be not beneficial in treating VCFs.

What are physicians' opinion on this?

How have these findings affected the global MIVCF treatment market?

Author(s): Monica Lin, BSc

image1

Monica Lin is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, focusing on the sports medicine, spinal implant, vertebral compression fracture treatment, and skin replacement and substitute markets. Monica holds an Honors Bachelor's degree in Life Physics and Economics from the University of Waterloo.


Table of Contents

Global

Abstract

Executive Summary

  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Geographies Covered
  • Procedures Covered
  • Products Covered

Key Report Updates

MIVCF Treatment Market

  • Market Highlights
  • US
  • Europe
  • Asia Pacific
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
  • Clinical Data
  • Reimbursement
  • Pricing Strategies and Purchasing Options
  • Mergers, Acquisitions, and Partnerships
  • Physician Training and Marketing
  • First-Mover Advantage
  • Product Improvements and Innovations
  • Market Developments

Vertebroplasty Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Vertebral Augmentation Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography